InvestorsHub Logo
Followers 54
Posts 6680
Boards Moderated 0
Alias Born 01/11/2017

Re: None

Wednesday, 01/11/2017 10:25:13 PM

Wednesday, January 11, 2017 10:25:13 PM

Post# of 233467
One can debate if Trump's bloviating about Pharma and Bio companies today hurt the stock, but I believe it put the brakes on it a bit. It should rally through end of week.

My theory, for what it's worth is this: GILD has a former Sr. Executive on the BoD for CYDY. His bio is very impressive and this is what he does....

I suspect the BoD is doing things to keep this stock below $1 to keep large investors from trading it as many are not allowed to trade OTC stocks. I've seen some people criticizing the CEO and his lack of pharma experience. With five employees, it is quite obvious these guys have ZERO intention of getting into the manufacturing and distribution of pharmaceuticals.

I strongly believe GILD has a handshake deal and is supporting Nader, both financially and with the expertise of former exec's. Nader is simply the face of the company. Keeping the stock low and on the OTC keeps the big-game hunters out of the woods and GILD can pay a pre-determined price once this is approved. (Charlie all but said it's getting approved on GMA and Nader said it's gonna "be a Golden Quarter" for us".

Look at the trend of this stock. It is literally months, if not weeks, from getting approved as a breakthrough drug for HIV that has proven results over YEARS and is trading at $.73! Give me a break.

Let's all sit back and profit from this deal of a lifetime....as a disclaimer, I'm not an investor. I actually found this company from reading a story about Charlie Sheen a few months back and he mentioned PRO140, so I did some analysis. I'm in for 40K shares at an avg pps of $.64. As Charlie would say: "WINNING!!"

Can't hardly wait for Valentines Day!

Grip It and Sip It baby!!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News